keyword
MENU ▼
Read by QxMD icon Read
search

Bupropion

keyword
https://www.readbyqxmd.com/read/28631318/bupropion-overdose-resulted-in-a-pharmacobezoar-in-a-fatal-bupropion-wellbutrin-%C3%A2-sustained-release-overdose-postmortem-distribution-of-bupropion-and-its-major-metabolites
#1
Gregory Schmit, Evy De Boosere, Jessica Vanhaebost, Arnaud Capron
Bupropion (BUP) overdose commonly causes generalized seizures and central nervous system depression. The case of a 28-year-old woman who died from a massive lethal overdose with sustained-release bupropion (Wellbutrin(®) 300 mg) is herein presented. The autopsy revealed the presence of a pharmacobezoar consisting of at least 40 tablets in the stomach. Determination of bupropion and its active metabolites (hydroxybupropion, threobupropion, erythrobupropion) was achieved by a liquid chromatographic mass spectrometry (LC-MS/MS) method...
June 20, 2017: Journal of Forensic Sciences
https://www.readbyqxmd.com/read/28628765/emotional-blunting-with-antidepressant-treatments-a-survey-among-depressed-patients
#2
G M Goodwin, J Price, C De Bodinat, J Laredo
BACKGROUND: Emotional blunting is regularly reported in depressed patients on antidepressant treatment but its actual frequency is poorly understood. We have previously used qualitative methods to develop an appropriate scale, the Oxford Questionnaire on the Emotional Side-Effects of Antidepressants (OQESA). METHODS RESULTS: Six hundred and sixty nine depressed patients on treatment and 150 recovered (formerly depressed) controls (aged ≥18 years) participated in this internet-based survey...
June 6, 2017: Journal of Affective Disorders
https://www.readbyqxmd.com/read/28624760/how-do-smoking-cessation-medicines-compare-with-respect-to-their-neuropsychiatric-safety-a-protocol-for-a-systematic-review-network-meta-analysis-and-cost-effectiveness-analysis
#3
Kyla H Thomas, Deborah Caldwell, Michael N Dalili, David Gunnell, Marcus R Munafò, Matt Stevenson, Nicky J Welton
INTRODUCTION: Cigarette smoking is one of the leading causes of early death in the UK and worldwide. Public health guidance recommends the use of varenicline, bupropion and nicotine replacement therapy (NRT) as smoking cessation aids in the UK. Additionally, the first electronic cigarette has been licensed for use as a smoking cessation medicine. However, there are ongoing concerns about the safety of these medicines. We present a protocol for a systematic review and network meta-analysis (NMA) to determine how these smoking cessation medicines compare to each other with respect to their neuropsychiatric safety in adult smokers...
June 17, 2017: BMJ Open
https://www.readbyqxmd.com/read/28622213/selective-serotonin-reuptake-inhibitor-induced-hyponatremia-clinical-implications-and-therapeutic-alternatives
#4
María Varela Piñón, Jaime Adán-Manes
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed among the general population. Despite their benign side effect profile, these drugs can cause significant adverse effects in elderly patients, including severe hyponatremia. We report 1 case of SSRI-induced hyponatremia and review therapeutic alternatives. CASE: We present an 81-year-old male patient treated with sertraline and furosemide who presented with a recent-onset symptomatic hyponatremia...
June 16, 2017: Clinical Neuropharmacology
https://www.readbyqxmd.com/read/28622206/bupropion-augmentation-in-a-case-of-compulsive-buying-disorder
#5
Gianna Sepede, Giuseppe Di Iorio, Fabiola Sarchione, Federica Fiori, Massimo Di Giannantonio
BACKGROUND: Compulsive buying disorder (CBD) is a condition characterized by excessive preoccupations, impulses, and behaviors regarding buying, resulting in serious psychological, social, and financial problems. Even though it has not been included in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, "behavioral addictions" section, CBD is a hot topic in current clinical psychiatry, because of its relevant prevalence (at least 5% in adult populations) and severe effect on quality of life...
June 16, 2017: Clinical Neuropharmacology
https://www.readbyqxmd.com/read/28615911/bupropion-and-iron-for-restless-leg-syndrome-do-they-have-efficacy-similar-to-ropinirole
#6
Samir Kumar Praharaj
No abstract text is available yet for this article.
April 2017: Annals of Indian Academy of Neurology
https://www.readbyqxmd.com/read/28608452/chiral-separation-and-modeling-of-baclofen-bupropion-and-etodolac-profens-on-amylose-reversed-phase-chiral-column
#7
Imran Ali, Mohd Suhail, Zeid A Alothman, Abdulrahman Alwarthan
Chiral resolution of baclofen, bupropion, and etodolac profens was obtained with amylose derivatized chiral reversed stationary phase (carbamate groups). The eluent used for bupropion and etodolac was MeOH-water (20:80, v/v) and for baclofen was water-methanol (95:5, v/v). The eluent run rates, finding wavelength and temperature, were 1.0 mL/min, 220 nm and 27 ± 1 °C for all the eluents. The magnitude of the retardation factors for S- and R-enantiomers of baclofen, bupropion, and etodolac were 1.37, 2...
July 2017: Chirality
https://www.readbyqxmd.com/read/28605678/trends-in-utilization-of-smoking-cessation-agents-before-and-after-the-passage-of-fda-boxed-warning-in-the-united-states
#8
Drishti Shah, Anuj Shah, Xi Tan, Usha Sambamoorthi
BACKGROUND: In 2009, the FDA required a black box warning (BBW) on bupropion and varenicline, the two commonly prescribed smoking cessation agents due to reports of adverse neuropsychiatric events. We investigated if there was a decline in use of bupropion and varenicline after the BBW by comparing the percent using these medications before and after BBW. METHODS: We conducted a retrospective observational study using data from the Medical Expenditure Panel Survey from 2007 to 2014...
May 18, 2017: Drug and Alcohol Dependence
https://www.readbyqxmd.com/read/28605035/cardiovascular-adverse-events-in-the-drug-development-program-of-bupropion-for-smoking-cessation-a-systematic-retrospective-adjudication-effort
#9
Jessie Kittle, Renato D Lopes, Mingyan Huang, Marsha L Marquess, Matthew D Wilson, John Ascher, Alok Krishen, Vic Hasselblad, Brad J Kolls, Matthew T Roe, Darren K McGuire, Stuart D Russell, Kenneth W Mahaffey
BACKGROUND: In 2011, the US Food and Drug Administration requested that GlaxoSmithKline perform retrospective adjudication of cardiovascular (CV) events reported in the bupropion drug-development trials for smoking cessation. HYPOTHESIS: Retrospective adjudication of clinical trial data will not increase the identification of adverse events. METHODS: We performed a comprehensive retrospective analysis of adverse events in 19 previously completed controlled US clinical trials of bupropion marketed for the treatment of smoking cessation, yielding 9479 subjects (5290 bupropion, 2927 placebo, 1018 active control [ACT], and 244 treated concurrently with bupropion and ACT)...
June 12, 2017: Clinical Cardiology
https://www.readbyqxmd.com/read/28604472/perioperative-pain-management-of-a-patient-taking-naltrexone-hcl-bupropion-hcl-contrave-a-case-report
#10
Allen Ninh, Sang Kim, Andrew Goldberg
A 42-year-old obese woman (body mass index = 30.2 kg/m) presented for urgent anterior cervical diskectomy and fusion. She had been taking oral naltrexone-bupropion extended-release (Contrave, Orexigen Therapeutics Inc, La Jolla, CA) for the past 6 months and continued using it until 12 hours preoperatively. Despite discontinuation of this medication, and employing an intraoperative and postoperative multimodal analgesia strategy, immediate pain control was inadequately achieved. Patients taking opioid antagonists who present for surgery pose unique challenges to the anesthesiologist and require extensive preoperative interdisciplinary discussions and planning for pain control throughout the perioperative period...
June 8, 2017: A & A Case Reports
https://www.readbyqxmd.com/read/28595558/the-role-of-placental-carbonyl-reducing-enzymes-in-biotransformation-of-bupropion-and-4-methylnitrosamino-1-3-pyridyl-1-butanone
#11
Valentina M Fokina, Svetlana L Patrikeeva, Cheryl Oncken, Gary Dv Hankins, Mahmoud S Ahmed, Tatiana N Nanovskaya
BACKGROUND: Bupropion (BUP) has a potential to be an effective pharmacotherapy for smoking cessation during pregnancy. Smoking during pregnancy stimulates placental carbonyl reductases that catalyze the biotransformation of BUP. 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen of cigarette smoke. Carbonyl reduction of NNK into 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (NNAL) constitutes a major step in NNK detoxification. Thus, placentas of pregnant smokers on BUP therapy can become a site of drug-drug interaction...
June 6, 2017: Drug Metabolism Letters
https://www.readbyqxmd.com/read/28595525/obesity-induced-hypertension-new-insights
#12
Christina Antza, Stella Stabouli, Michalis Natsis, Ioannis Doundoulakis, Vasilios Kotsis
BACKGROUND: New insights on the relationship between weight loss and hypertension and the role of the newly approved anti-obesity drugs on hypertension will be discussed Methods: Weight loss is a major factor to reduce blood pressure when a patient with excess weight is advised from the health care provider to change his lifestyle. A healthy lifestyle with reduction in body weight, reduction in caloric intake, increased fruit and vegetables consumption and reduced salt intake concomitant with an increase in physical exercise can reduce body weight and hypertension in overweight and obese patients, but not all obese are able to reduce their blood pressure and lose weight without treatment and special dietary care...
June 7, 2017: Current Pharmaceutical Design
https://www.readbyqxmd.com/read/28595356/treatment-with-bupropion-and-varenicline-for-smoking-cessation-and-the-risk-of-acute-cardiovascular-events-and-injuries-a-swedish-case-crossover-study
#13
Joel Monárrez-Espino, Maria Rosaria Galanti, Jenny Hansson, Imre Janszky, Karin Söderberg, Jette Möller
Introduction: Bupropion and varenicline are non-nicotine medications used for smoking cessation that mitigate craving and withdrawal symptoms. We aim to investigate whether these drugs increase the risk of selected acute adverse outcomes when used in medical practice. Methods: Population-based case-crossover design using data from Swedish health and administrative registers. Adult individuals diagnosed with acute myocardial infarction, stroke, suicide, suicide attempt, fall injury, or that suffered a road traffic crash from 01...
June 8, 2017: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
https://www.readbyqxmd.com/read/28593623/-smoking-cessation-and-schizophrenia
#14
D P Muller, L de Haan
People with schizophrenia smoke about 5.6 times as much as people without the disease. This factor is a major but treatable cause of morbidity and mortality in this patient population. Nevertheless, health professionals make relatively little effort to discourage people from smoking or to give it up altogether.<br/> AIM: To increase health professionals' knowledge about possible therapeutic interventions that can help people with schizophrenia to stop smoking.<br/> METHOD: We studied the relevant literature...
2017: Tijdschrift Voor Psychiatrie
https://www.readbyqxmd.com/read/28591669/bupropion-induces-social-anxiety-in-adolescent-mice-influence-of-housing-conditions
#15
Carmen Gómez, Rosa Redolat, Carmen Carrasco
BACKGROUND: The antidepressant bupropion has received increasing attention as a pharmacological tool to treat addiction although little is known about its effects on social behaviour in adolescents. The present study aimed to evaluate if environmental housing conditions influence bupropion's actions on social behaviour of adolescent mice. METHODS: Mice were either group- or individually housed for 2-weeks and then randomly divided into 2 cohorts: half of the mice remained in the initial housing condition and the other half were changed to isolated conditions for further 2-weeks...
March 22, 2017: Pharmacological Reports: PR
https://www.readbyqxmd.com/read/28590371/cocaine-abuse-traumatic-brain-injury-and-preexisting-brain-lesions-as-risk-factors-for-bupropion-associated-psychosis
#16
Rajdip Barman, Sanjeev Kumar, Bhuvaneshwar Pagadala, Mark B Detweiler
BACKGROUND AND OBJECTIVE: Bupropion is generally considered safe and is widely used both as a monotherapy and as an augmentation agent for the treatment of major depression. Concerns have been raised about bupropion's propensity to precipitate new psychosis and worsen existing psychotic symptoms, although the mechanism is poorly understood. Three cases are reported in which bupropion use was associated with psychosis. The aim of the study was to explore the risk factors and possible mechanisms of psychosis in each case...
June 5, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28574863/mephentermine-dependence-in-a-young-athlete-case-report-with-review-of-literature
#17
Swarndeep Singh, Ankit Gupta, Siddharth Sarkar
: Mephentermine is structurally related to amphetamines and is banned for its use as a performance-enhancing drug in competitive sports. Limited literature is available on management of mephentermine dependence. Here, we describe a case of mephentermine dependence followed by review of literature and a discussion about its management. A 20-year-old professional wrestler presented with high-dose intravenous mephentermine use, and rapid development of dependence, in the absence of any comorbid substance use or psychiatric disorder...
June 1, 2017: Journal of Addiction Medicine
https://www.readbyqxmd.com/read/28570500/concurrent-electroconvulsive-therapy-and-bupropion-treatment
#18
Christopher R Takala, Jonathan G Leung, Lauren L Murphy, Jennifer R Geske, Brian A Palmer
BACKGROUND: Bupropion is associated with a dose-dependent increased risk of seizures. Use of concomitant bupropion and electroconvulsive therapy (ECT) remains controversial because of an increased risk of prolonged seizures. This is the first systematic evaluation of the effect of bupropion on ECT. METHODS: A case group (n = 119), patients treated with concomitant ECT and bupropion, was compared with an age and gender frequency-matched control group (n = 261), treated with only ECT...
May 31, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28556464/tobacco-harms-nicotine-pharmacology-and-pharmacologic-tobacco-cessation-interventions-for-women
#19
REVIEW
L Kim Baraona, Dawn Lovelace, Julie L Daniels, Linda McDaniel
Firsthand and secondhand tobacco use is linked to a multitude of harmful illnesses, adverse perinatal outcomes, and death. Cessation attempts among women may be hampered by their unique biologic response to nicotine. Current research has revealed epigenetic changes from intrauterine nicotine exposure that have intergenerational consequences. Multiple studies have demonstrated the efficacy of various pharmacologic tobacco cessation interventions in conjunction with behavioral counseling. Based on this evidence, the US Preventative Services Task Force (USPSTF) 2015 guideline recommends pharmacologic therapy for all nonpregnant persons who smoke in addition to behavioral counseling...
May 2017: Journal of Midwifery & Women's Health
https://www.readbyqxmd.com/read/28550660/achieving-smoking-cessation-in-individuals-with-schizophrenia-special-considerations
#20
REVIEW
Corinne Cather, Gladys N Pachas, Kristina M Cieslak, A Eden Evins
Premature mortality due to cardiovascular disease in those with schizophrenia is the largest lifespan disparity in the US and is growing; adults in the US with schizophrenia die, on average, 28 years earlier than those in the general population. The rate of smoking prevalence among individuals with schizophrenia is estimated to be from 64 to 79%. Smokers with schizophrenia have historically been excluded from most large nicotine-dependence treatment studies. However, converging evidence indicates that a majority of smokers with schizophrenia want to quit smoking, and that available pharmacotherapeutic smoking cessation aids are well tolerated by this population of smokers and are effective when combined with behavioral treatment...
June 2017: CNS Drugs
keyword
keyword
11519
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"